Prognostic correlation studies have shown that the overall survival (OS) of ZKSCAN3-positive gastric cancer patients was significantly shorter than that of negative patients, indicating its potential application as a biomarker and therapeutic target for evaluating prognosis in gastric cancer [71]. Here, ZKSCAN3 is linked to gastric cancer.